Malaria Cases Rise in APAC: Early Diagnosis Critical for Better Outcomes

Malaria continues to pose a significant health challenge across APAC, with millions at risk and the growing threat of drug-resistant strains demanding renewed focus and action. According to the WHO World Malaria Report 2025, malaria accounted for an estimated 282 million cases and 610,000 deaths in 2024. Early and accurate diagnosis remains critical. Advanced diagnostics—including hematology insights—can support early suspicion, timely detection, and better clinical decision-making. At Beckman Coulter, we are committed to advancing diagnostic innovation that supports laboratories and healthcare systems in improving patient outcomes across the region. Learn more about our hematology solutions: https://bit.ly/3EJBRoC Together, through innovation and collaboration, we can accelerate the fight against malaria. 🌍🦟 #WorldMalariaDay #EndMalaria #Hematology #APACHealthcare

On World Malaria Day, we reaffirm our commitment to accelerating the fight against malaria. While progress has been made, malaria continues to pose a significant health burden. Globally, there are an estimated 249 million cases and over 600,000 deaths each year, underscoring the urgent need for timely diagnosis and effective disease management. In many settings, hematology analyzers play a critical role in early screening—flagging abnormalities such as changes in platelet count and red blood cell parameters that can support suspicion of malaria and prompt further confirmatory testing. At Beckman Coulter, we are committed to pioneering hematology that deliver reliable insights—supporting faster clinical decisions and improved patient outcomes. Together, through innovation and collaboration, we can move closer to a malaria-free future. #WorldMalariaDay #Malaria #Hematology

On World Malaria Day, we reaffirm our commitment to accelerating the fight against malaria. While progress has been made, malaria continues to pose a significant health burden. Globally, there are an estimated 249 million cases and over 600,000 deaths each year, underscoring the urgent need for timely diagnosis and effective disease management. In many settings, hematology analyzers play a critical role in early screening—flagging abnormalities such as changes in platelet count and red blood cell parameters that can support suspicion of malaria and prompt further confirmatory testing. At Beckman Coulter, we are committed to pioneering hematology that deliver reliable insights—supporting faster clinical decisions and improved patient outcomes. Together, through innovation and collaboration, we can move closer to a malaria-free future. #WorldMalariaDay #Malaria #Hematology

In 2023 we published the first human clinical trial on antimicrobial photodynamic therapy for malaria. 120 patients. Riboflavin, light, and a mechanism that pathogens cannot develop resistance against. The study results were strong. But what stays with me are the cases from the field. Our colleague Petra Kscheschinski had a patient return from Kenya on a Friday in full acute malaria. The tropical medicine clinic couldn't see her until Monday. Petra treated her Saturday and Sunday with riboflavin, artesunate, and laser. Monday the clinic found zero measurable parasites and told her she probably just had a virus. In Kenya, Petra treated cerebral malaria patients, cases the hospitals in Nairobi had no answer for. Yellow eyes. Cognitive impairment. Full recovery after one to two sessions. This is what 13 years of research looks like when it reaches patients who have no other options. If you want to read the full published study, drop a comment below and I'll share it.

🦟 World Malaria Day | Screening Needs More than CBC Limited access to microscopy, uneven expertise, and delayed workflows continue to challenge early malaria detection — especially in resource-limited settings. Ozelle extends screening beyond CBC with AI-powered morphology: 🔹 Parasite cell recognition 🔹 High / medium / low risk indication 🔹 A practical approach to early malaria screening Because in malaria, earlier insight means earlier action. 🤝 Get in touch: https://lnkd.in/gEfxCCa9 🔗 Learn more: www.ozellemed.com #WorldMalariaDay #Malaria #Diagnostics #Hematology #MedicalTechnology #Ozelle

We are definitely a technology that is forward thinking ,Africa needs a solution and this is what can change the landscape.#AI #malaria #Poctheamatology

Malaria continues to be a major global health challenge—causing nearly 250 million infections and over 600,000 deaths each year, with children among the most vulnerable. Nearly half of the world’s population remains at risk. This World Malaria Day, explore a compelling case study of Plasmodium malariae in a 42-year-old patient—highlighting the complexities of diagnosis, the role of vectors, the growing impact of climate change, and ongoing advancements in diagnostics and vaccines. As malaria remains difficult to identify in its early stages, advanced diagnostics including hematology insights play a critical role in raising suspicion and supporting timely detection. Read the full case and discover one patient’s journey to diagnosis, along with the broader challenges and hope for eradication: https://bit.ly/3YlGl0P #WorldMalariaDay #EndMalaria #Malaria #Hematology #MalariaDiagnosis

Malaria continues to be a major global health challenge—causing nearly 250 million infections and over 600,000 deaths each year, with children among the most vulnerable. Nearly half of the world’s population remains at risk. This World Malaria Day, explore a compelling case study of Plasmodium malariae in a 42-year-old patient—highlighting the complexities of diagnosis, the role of vectors, the growing impact of climate change, and ongoing advancements in diagnostics and vaccines. As malaria remains difficult to identify in its early stages, advanced diagnostics including hematology insights play a critical role in raising suspicion and supporting timely detection. Read the full case and discover one patient’s journey to diagnosis, along with the broader challenges and hope for eradication: https://bit.ly/3YlGl0P #WorldMalariaDay #EndMalaria #Malaria #Hematology #MalariaDiagnosis

Understanding the life cycle of malaria is not just academic — it is the foundation of accurate diagnosis, effective treatment, and global disease control. This illustration beautifully demonstrates the complex journey of the Plasmodium parasite between the mosquito vector and the human host, highlighting: • Liver stage development • Asexual blood-stage replication • Sexual differentiation and transmission • Targeted action of antimalarial drugs at different stages As laboratory professionals and healthcare workers, recognizing these stages is essential for: 🔬 Accurate microscopic identification 💉 Timely therapeutic intervention 🧪 Understanding drug mechanisms and resistance 🌍 Supporting malaria prevention and eradication programs Every blood smear examined in the laboratory contributes to a much larger fight against one of the world’s most significant parasitic diseases. #Malaria #Parasitology #MedicalLaboratoryScience #LaboratoryTechnician #Microbiology #Healthcare #Diagnostics #MedicalEducation #PublicHealth #LaboratoryMedicine #Pathology #BiomedicalScience

A promising new approach to #malaria treatment. A clinical trial led by Assoc Professor Bridget Barber and Professor Christian Engwerda from QIMR Berghofer, in partnership with the UniSC Clinical Trials, has found that ruxolitinib—a drug used for blood disorders—may enhance the body’s ability to fight malaria. Used alongside existing treatments, it could support faster recovery and stronger immune protection. Click the link below to learn more about this exciting trial! World Malaria Day - Now we can. Now we must. UniSC University of the Sunshine Coast #WorldMalariaDay #Mosquito #NowWeCan #DrugRepurposing #ClinicalTrial https://lnkd.in/gWS92Ufm